Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financi... (EQUIPMENT net 7189361...)

Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financial Results

Date:5/15/2009

EQUIPMENT, net 71,893,618 69,943,021 OTHER ASSETS: Investment in Changle Shengshi Redian Co., Ltd. 3,739,131 3,607,912 Loan to related party - noncurrent -- 437,700 Intangible assets - land use right, net of accumulated amortization 3,494,976 3,042,183 Total other assets 7,234,107 7,087,795 Total assets $ 105,027,260 $ 101,313,662 LIABILITIES AND SHAREHOLDERS' EQUITY CURRENT LIABILITIES: Notes payable - banks $ 13,185,000 $ 10,942,500 Accounts payable 6,289,009 7,669,728 Accounts payable - related parties 637,792 714,776 Short term loans 22,707,500 22,658,270 Accrued liabilities 212,595 261,187 Other payable 2,917,200 2,146,108 Employee loans 841,297 1,382,287 Employee loan - officer 43,549 53,605 Third party loan 192,642 640,228 Customer deposit 1,729,702 804,323 Taxes payable 2,618,424 4,631,252 Current portion of capital lease obligations 398,862 -- Total current liabilities 51,773,572 51,904,264 LONG TERM LIABILITIES: Capital lease obligation 4,875,368 -- Other payable - noncurrent 1,424,044 2,653,995 Total long term liabilities 6,299,412 2,653,995 Total liabilities

SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:11/30/2009)...re/ -- Harrington Physician Services (HPS) is plea...ysicians Martin Devine, Leah Doret, Elizabeth Full..., These four esteemed and popular Charlton-base...soon join the Harrington family in the new Harring... under construction at 10 North Main Street, at th...

(Date:11/30/2009)...registration of a visual stimulus by the unconscio...; between the time we see an apple and the time we...r eyes, but by how long? And how does this affect ...stimates say the time delay lasts only 100 millise... Tel Aviv University psychologists says that the a...

(Date:11/30/2009)...y designed program, study finds , , MOND...ve early intervention program for toddlers with au...s language and social skills, a new study shows. ,...able to learn and make remarkable progress," said ...hed online Nov. 30 in Pediatrics , and chief sci...

(Date:11/30/2009)...0 Sunlamps and tanning ...but the ultraviolet (UV) radiation from these devi...p://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ...ves them a ,healthy, glow, any tan is a sign of sk...nd Drug Administration (FDA) scientist and interna...

(Date:11/30/2009)...Physicians at Beth Israel Deaconess Medical Center...onstrating the potential for automated analysis of...alyzer System® to assist in rapidly ruling ou...epartment (ED ) patients with chest pain. The abil...cCTA has potential to significantly reduce unneces...

Breaking Medicine News(10 mins):Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 2 Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 3 Health News:Now you see it, now you know you see it 2 Health News:Working Intensely Early on May Help Autistic Kids 2 Health News:Working Intensely Early on May Help Autistic Kids 3 Health News:Working Intensely Early on May Help Autistic Kids 4 Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 2 Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 3

[0] Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton [0] Now you see it, now you know you see it [0] Working Intensely Early on May Help Autistic Kids [0] Indoor Tanning: The Risks of Ultraviolet Rays [0] Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease

... Texas, Nov. 6 The following was released today,b...eport from the U.S. Department of Veterans Affairs...1105-171) substantiated waste,mismanagement and in...ion to these serious disclosures constitutes viola...

... Net Sales increase 73% over Third Quarter 2007, ...Inc. (Nasdaq: ONXX ) today reported its financial...mber 30, 2008. Onyx reported net,income of $12.2 m...d in 2007. Excluding employee stock-based compensa...

...LOS, Calif., Nov. 6 Nektar,Therapeutics (Nasdaq: ...%, or,$100.0 million, of its outstanding convertib...for a total purchase price of $47.8 million. The,c...complete," said Nektar,President and CEO Howard W....

...errals should start with emergency room doctors, s...News) -- For children and teens who suffer violenc...oring on how to safely avoid conflict and diffuse ...ding gunshot, knife and fist-fight wounds -- at em...

... PfP Launches Ad Campaign Calli... , Washington, DC (PRWEB)...for Prevention said today that President-elect Oba...rdingly, the organization launched an ad campaign ...

...nce Call Scheduled for Today - Thursday, November ...tern Time, MOUNTAIN VIEW, Calif., Nov. 6 Alexza,...day financial results for,the quarter and nine mon...nded September 30, 2008, as reported in accordance...

War Veterans With Traumatic Brain Injury Pay the Price of Waste at the VA, Says Dr. Robert Van Boven Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results Counseling Can Combat Youth Violence Obama's Call for "Change We Can Believe In" Makes Prevention a Priority in Health Reform Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates

(Date:11/30/2009)..., , COVINA, Calif., Nov. 30 /PRNewswire... and commercialization agreement with Academia Sin...n proprietary methods and Intellectual Property (I... stem cells. This method and IP was pioneered by ...ers of Academia Sinica. Professor Lin is currentl...

(Date:11/30/2009)..., , KING OF PRUSSIA, Pa., Nov. 30 /PRNew...unced the completion of a Phase I study of CPSI-23... the production of TNF-alpha and other pro-inflamm...bility dose escalation study in healthy volunteers...inical testing. ,, All 30 enrolled subjects c...

(Date:11/30/2009)..., , WALTHAM, Mass., Nov. 30 /PRNews...RG), the global authority on medical technology ma...facial injectable market declined by almost 5% ove...ent as a result of the economic crisis. The market...4, will return to the strong pre-recession growth ...

Breaking Medicine Technology:StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2 StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3 Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2 Facial Injectables Emerge From the Recession 2 Facial Injectables Emerge From the Recession 3 Centene Corporation to Present at Bank of America Merrill Lynch Credit Conference 61862 1 Why Holidays Dont Have To Be Happy 61860 1 Why Holidays Dont Have To Be Happy 61860 2 SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 1 SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 2 SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 3 SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 4 SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 5

[0] StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke [0] Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 [0] Facial Injectables Emerge From the Recession

...ImmuneRegen and TGen Continue Testing Possible Tre...apy Adjuvant Likely Targeting Adult Stem ... Ariz., Aug. 27 ImmuneRegen,BioSciences, Inc., a ...,Inc. (OTC Bulletin Board: IRBO), today announced ... Services), an affiliate of The Translational,Geno...

...BRISBANE, Australia, Aug. 24 Physicians at Southe...designed to test the,efficacy of a new strategy fo...e toughest infectious diseases in the modern world..., which works as a,regulator of the body,s immune ...ion to patients with chronic hepatitis C viral inf...

Other Medicine Technology:ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells 2 ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells 3 ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells 4 Drug in New Hepatitis C Clinical Trial 2

ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells Drug in New Hepatitis C Clinical Trial

Sealing Mat for 384-well PCR plate

MicroAmp 24-Well Full Plate Covers

Eppendorf Sealing Mat 96

AlumaSeal Aluminum sealing film for multiwell plates

Medicine Products:

Sealing Mat for 384-well PCR plate MicroAmp 24-Well Full Plate Covers Eppendorf Sealing Mat 96 AlumaSeal Aluminum sealing film for multiwell plates

Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financi...(EQUIPMENT net 7189361...),Health